Newly Recruiting Clinical Trials

Shows clinical trials that have started to recruit within the selected timeframe

Search Results

There are 5 clinical trial(s) matching the criteria.

Multicenter, Open Label, Phase 3 Trial of Allogeneic Epstein-Barr Virus Cytotoxic T Lymphocytes (EBV-CTLs) for Solid Organ Transplant (SOT) Patients with EBV-Associated Post Transplant Lymphoproliferative Disease (EBV-PTLD) after Failure of Rituximab or Rituximab and Chemotherapy

Investigator: Amer Beitinjaneh

Institutional Protocol #: 20161025

National Clinical Trials Identifier: NCT03394365

Division: Cancer Center

Therapeutic Area: Leukemia, Lymphoma, and Myeloma

Phase: Phase III

Enrolling Since: 4/11/2018